Sodium Bicarbonate
- Product NDC
- 72572-740
- Requested package NDC
- 72572-740-25
- 11-digit product format
- 725720740
- Labeler code
- 72572
- Product ID
- 72572-740_8fcbd37e-e4d5-4137-9abf-c398fbb5cbf0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- SODIUM BICARBONATE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Civica
- Application
- ANDA211091
- Marketing category
- ANDA
- Marketing start
- 2019-08-01
- Substance
- SODIUM BICARBONATE
- Active strength
- 84 mg/mL
- Pharmacologic classes
- Alkalinizing Activity [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A211091-001 | SODIUM BICARBONATE | SODIUM BICARBONATE | 5MEQ/10ML (0.5MEQ/ML) | SOLUTION / INTRAVENOUS | AP | RS | 2019-06-20 |
| A211091-002 | SODIUM BICARBONATE | SODIUM BICARBONATE | 44.6MEQ/50ML (0.9MEQ/ML) | SOLUTION / INTRAVENOUS | AP | RS | 2019-06-20 |
| A211091-003 | SODIUM BICARBONATE | SODIUM BICARBONATE | 10MEQ/10ML (1MEQ/ML) | SOLUTION / INTRAVENOUS | AP | RS | 2019-06-20 |
| A211091-004 | SODIUM BICARBONATE | SODIUM BICARBONATE | 50MEQ/50ML (1MEQ/ML) | SOLUTION / INTRAVENOUS | AP | RS | 2019-06-20 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A211091-001 | AP |
| A211091-002 | AP |
| A211091-003 | AP |
| A211091-004 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A211091-001 | SODIUM BICARBONATE | 5MEQ/10ML (0.5MEQ/ML) | SOLUTION / INTRAVENOUS | AP | RS | 2019-06-20 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A211091-002 | SODIUM BICARBONATE | 44.6MEQ/50ML (0.9MEQ/ML) | SOLUTION / INTRAVENOUS | AP | RS | 2019-06-20 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A211091-003 | SODIUM BICARBONATE | 10MEQ/10ML (1MEQ/ML) | SOLUTION / INTRAVENOUS | AP | RS | 2019-06-20 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A211091-004 | SODIUM BICARBONATE | 50MEQ/50ML (1MEQ/ML) | SOLUTION / INTRAVENOUS | AP | RS | 2019-06-20 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A211091-001 | AP | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A211091-002 | AP | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A211091-003 | AP | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A211091-004 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Bicarbonate | SODIUM BICARBONATE | Exela Pharma Sciences, LLC | 2f05947f-a489-4298-a871-90db75b2a6c5 | 2026-06-09 | Warnings, Adverse reactions | 211091 ANDA211091 |
| Sodium Bicarbonate | SODIUM BICARBONATE | Civica | a10fdfbc-94a0-49ab-b26c-de1df042bc89 | 2025-11-24 | Warnings, Adverse reactions | 211091 ANDA211091 72572-740-25 72572-740 72572074025 |
| Sodium Bicarbonate | SODIUM BICARBONATE | A-S Medication Solutions | d89406d3-4356-4a8c-acc1-89efe1d27010 | 2023-11-14 | Warnings, Adverse reactions | 211091 ANDA211091 |
| Sodium Bicarbonate | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | 09cf38c2-0b44-eca1-e063-6294a90a72d8 | 2023-11-10 | Warnings, Adverse reactions | 211091 ANDA211091 |
| Sodium Bicarbonate | SODIUM BICARBONATE | Exela Pharma Sciences, LLC | e9698a4f-1a95-4f28-a945-e8009d1d6dd4 | 2017-09-27 | Warnings, Adverse reactions | 211091 ANDA211091 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Sodium Bicarbonate
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SODIUM BICARBONATE | 84 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 8MDF5V39QO | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1868486 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| a10fdfbc-94a0-49ab-b26c-de1df042bc89 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fb7ab793-2c12-4079-b100-a64f73bef25a | Product name | 4 | 20240712 |
| b0cbf770-6cc3-4aa4-9158-755110c2b9f7 | Product name | 2 | 20230717 |
| dc7c5daa-021f-40dd-b00d-63982cb2067a | Product name | 1 | 20230426 |
| 08ffbcbf-26df-b99c-1dab-64fc4cfae89f | Product name | 5 | 20200925 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 08ffbcbf-26df-b99c-1dab-64fc4cfae89f | Product name | 2 | 20160823 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72572-740-25 | Sodium Bicarbonate | 50 mL in 1 VIAL | INJECTION, SOLUTION | 50 | 3 | |
| 72572-740-25 | Sodium Bicarbonate | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72572-740-20 | ML - Milliliter | 72572-740 | de9e6ea1-44c0-4ede-ba0f-913e3b774e5e | 1 | 2020-03-10 |
| 72572-740-25 | ML - Milliliter | 72572-740 | 14ae7843-8fe6-4e55-b46b-a294931094da | 1 | 2024-04-05 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1868486 | sodium bicarbonate 8.4 % (50 MEQ) in 50 ML Injection | PSN | a10fdfbc-94a0-49ab-b26c-de1df042bc89 | 3 |
| 1868486 | 50 ML sodium bicarbonate 84 MG/ML Injection | SCD | a10fdfbc-94a0-49ab-b26c-de1df042bc89 | 3 |
| 1868486 | 50 ML NaHCO3 84 MG/ML Injection | SY | a10fdfbc-94a0-49ab-b26c-de1df042bc89 | 3 |
| 1868486 | sodium bicarbonate 8.4 % (50 MEQ) per 50 ML Injection | SY | a10fdfbc-94a0-49ab-b26c-de1df042bc89 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 72572-740-25 | 72572074025 | 25 VIAL in 1 CARTON (72572-740-25) / 50 mL in 1 VIAL | 25 vial | 2024-02-01 | No | No | Current |